Caracterización del comportamiento del virus Zika durante el periodo de enero a diciembre de 2017 en el Policlínico “26 de Julio”

Beatriz Caballero Fernández, Elizabeth Marrero Santiesteban, Yerina Figueredo Mesa, Teresa Serrano Sánchez

Texto completo:

PDF

Resumen

Resumen

Objetivos: Describir los casos de Zika por grupos de edades, sexo y síntomas. Analizar los casos confirmados por consultorios, así como analizar por meses los casos sospechosos y confirmados de Zika

Resultados: En nuestro estudio prevalecen los pacientes del sexo femenino y el grupo de edad desde 20 hasta 44 años en ambos sexos. Los síntomas más comunes encontrados fueron rash, prurito y artralgias o mialgias y los consultorios médicos de mayor riesgo para la trasmisión de la enfermedad fueron el 6, 13 y 14. Siendo enero, marzo, mayo y septiembre los meses de mayor incidencia de presentación de la infección por el virus.

Conclusiones:

La infección por el virus Zika en nuestra área tuvo un comportamiento diferencial en cuanto al sexo y el grupo etario. Los pacientes mostraron un grupo de síntomas que se manifestaron unos con más frecuencia que otros, así como se detectaron consultorios médicos que poseen un alto riesgo para la trasmisión de la enfermedad. Por otra parte, se determinó que durante todo el año hay meses en los que la incidencia de la infestación se hace más evidente en toda la zona.

 

 

Palabras clave

Arbovirosis; Zika; incidencia; área de salud

Referencias

BIBLIOGRAFIA

(1) Gabaglia CR. Zika virus and diagnostics. Curr Opin Pediatr 2017 Feb;29(1):107-13.

(2) Ozawa H, Tajima S, Nakayama E, Kato K, Yamashita A, Sekizuka T, et al. Isolation and Complete Genome Sequencing of Zika Virus Imported from the Dominican Republic to Japan. Jpn J Infect Dis 2018 Jan 23;71(1):72-4.

(3) Talero-Gutierrez C, Rivera-Molina A, Perez-Pavajeau C, Ossa-Ospina I, Santos-Garcia C, Rojas-Anaya MC, et al. Zika virus epidemiology: from Uganda to world pandemic, an update. Epidemiol Infect 2018 Apr;146(6):673-9.

(4) Abbasi AU. ZIKA VIRUS INFECTION; VERTICAL TRANSMISSION AND FOETAL CONGENITAL ANOMALIES. J Ayub Med Coll Abbottabad 2016 Jan;28(1):1-2.

(5) Bautista LE. Maternal Zika virus infection and newborn microcephaly-an analysis of the epidemiological evidence. Ann Epidemiol 2018 Feb;28(2):111-8.

(6) Chibueze EC, Tirado V, Lopes KD, Balogun OO, Takemoto Y, Swa T, et al. Zika virus infection in pregnancy: a systematic review of disease course and complications. Reprod Health 2017 Feb 28;14(1):28-0285.

(7) Theel ES, Hata DJ. Diagnostic Testing for Zika Virus: a Postoutbreak Update. J Clin Microbiol 2018 Mar 26;56(4):JCM-17.

(8) Zorrilla CD, Garcia G, I, Garcia FL, De L, V. Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal Considerations. J Infect Dis 2017 Dec 16;216(suppl_10):S891-S896.

(9) Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S, Hennessey M, et al. Male-to-Male Sexual Transmission of Zika Virus--Texas, January 2016. MMWR Morb Mortal Wkly Rep 2016 Apr 15;65(14):372-4.

(10) Gornet ME, Bracero NJ, Segars JH. Zika Virus in Semen: What We Know and What We Need to Know. Semin Reprod Med 2016 Sep;34(5):285-92.

(11) Tan Y, Gong F, Li S, Ji S, Lu Y, Gao H, et al. Brief report: a new profile of terminal N-acetyllactosamines glycans on pig red blood cells and different expression of alpha-galactose on Sika deer red blood cells and nucleated cells. Glycoconj J 2010 May;27(4):427-33.

(12) Cevallos V, Ponce P, Waggoner JJ, Pinsky BA, Coloma J, Quiroga C, et al. Zika and Chikungunya virus detection in naturally infected Aedes aegypti in Ecuador. Acta Trop 2018 Jan;177:74-80. doi: 10.1016/j.actatropica.2017.09.029. Epub@2017 Oct 2.:74-80.

(13) Braga JU, Bressan C, Dalvi APR, Calvet GA, Daumas RP, Rodrigues N, et al. Accuracy of Zika virus disease case definition during simultaneous Dengue and Chikungunya epidemics. PLoS One 2017 Jun 26;12(6):e0179725.

(14) Carrillo-Hernandez MY, Ruiz-Saenz J, Villamizar LJ, Gomez-Rangel SY, Martinez-Gutierrez M. Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border. BMC Infect Dis 2018 Jan 30;18(1):61-2976.

(15) Chouin-Carneiro T, Vega-Rua A, Vazeille M, Yebakima A, Girod R, Goindin D, et al. Differential Susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika Virus. PLoS Negl Trop Dis 2016 Mar 3;10(3):e0004543.

(16) Fukutani KF, Kasprzykowski JI, Paschoal AR, Gomes MS, Barral A, de Oliveira CI, et al. Meta-Analysis of Aedes aegypti Expression Datasets: Comparing Virus Infection and Blood-Fed Transcriptomes to Identify Markers of Virus Presence. Front Bioeng Biotechnol 2018 Jan 11;5:84. doi: 10.3389/fbioe.2017.00084. eCollection@2017.:84.

(17) Balm MN, Lee CK, Lee HK, Chiu L, Koay ES, Tang JW. A diagnostic polymerase chain reaction assay for Zika virus. J Med Virol 2012 Sep;84(9):1501-5.

(18) Adachi K, Nielsen-Saines K. Zika clinical updates: implications for pediatrics. Curr Opin Pediatr 2018 Feb;30(1):105-16.

(19) Brenciaglia M, Noel TP, Fields PJ, Bidaisee S, Myers TE, Nelson WM, et al. Clinical, Serological, and Molecular Observations from a Case Series Study during the Asian Lineage Zika Virus Outbreak in Grenada during 2016. Can J Infect Dis Med Microbiol 2018 Feb 1;2018:4635647. doi: 10.1155/2018/4635647. eCollection@2018.:4635647.

(20) Cabral CM, Nobrega MEBD, Leite PLE, Souza MSF, Teixeira DCP, Cavalcante TF, et al. Clinical-epidemiological description of live births with microcephaly in the state of Sergipe, Brazil, 2015. Epidemiol Serv Saude 2017 Apr;26(2):245-54.

(21) Yoon D, Shin SH, Jang HC, Kim ES, Song EH, Moon SM, et al. Epidemiology and Clinical Characteristics of Zika Virus Infections Imported into Korea from March to October 2016. J Korean Med Sci 2017 Sep;32(9):1440-4.

(22) Griffin I, Zhang G, Fernandez D, Cordero C, Logue T, White SL, et al. Epidemiology of Pediatric Zika Virus Infections. Pediatrics 2017 Dec;140(6):eds-2044.

(23) Guerbois M, Fernandez-Salas I, Azar SR, Danis-Lozano R, Alpuche-Aranda CM, Leal G, et al. Outbreak of Zika Virus Infection, Chiapas State, Mexico, 2015, and First Confirmed Transmission by Aedes aegypti Mosquitoes in the Americas. J Infect Dis 2016 Nov 1;214(9):1349-56.

(24) Likos A, Griffin I, Bingham AM, Stanek D, Fischer M, White S, et al. Local Mosquito-Borne Transmission of Zika Virus - Miami-Dade and Broward Counties, Florida, June-August 2016. MMWR Morb Mortal Wkly Rep 2016 Sep 30;65(38):1032-8.

(25) Sebastian UU, Ricardo AVA, Alvarez BC, Cubides A, Luna AF, Arroyo-Parejo M, et al. Zika virus-induced neurological critical illness in Latin America: Severe Guillain-Barre Syndrome and encephalitis. J Crit Care 2017 Dec;42:275-281. doi: 10.1016/j.jcrc.2017.07.038. Epub@2017 Aug 9.:275-81.

(26) Seruyange E, Gahutu JB, Muvunyi CM, Katare S, Ndahindwa V, Sibomana H, et al. Seroprevalence of Zika Virus and Rubella Virus IgG among blood donors in Rwanda and in Sweden. J Med Virol 2018 Apr 16;10.

(27) Simkins J, Anjan S, Morillas-Rodriguez JA, Greissman SR, Abbo LM, Camargo JF, et al. Screening for Zika virus in deceased organ donors in Florida. Am J Transplant 2018 Mar;18(3):731-6.

(28) Yamanaka A, Moi ML, Takasaki T, Kurane I, Matsuda M, Suzuki R, et al. Utility of Japanese encephalitis virus subgenomic replicon-based single-round infectious particles as antigens in neutralization tests for Zika virus and three other flaviviruses. J Virol Methods 2017 May;243:164-171. doi: 10.1016/j.jviromet.2017.02.011. Epub@2017 Feb@20.:164-71.

(29) Zammarchi L, Stella G, Mantella A, Bartolozzi D, Tappe D, Gunther S, et al. Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J Clin Virol 2015 Feb;63:32-5. doi: 10.1016/j.jcv.2014.12.005. Epub@2014 Dec 12.:32-5.

(30) Zammarchi L, Tappe D, Fortuna C, Remoli ME, Gunther S, Venturi G, et al. Zika virus infection in a traveller returning to Europe from Brazil, March 2015. Euro Surveill 2015 Jun 11;20(23).).

(31) Miller E, Becker Z, Shalev D, Lee CT, Cioroiu C, Thakur K. Probable Zika virus-associated Guillain-Barre syndrome: Challenges with clinico-laboratory diagnosis. J Neurol Sci 2017 Apr 15;375:367-370. doi: 10.1016/j.jns.2017.02.029. Epub@2017 Feb 14.:367-70.

(32) Castell-Florit SP, Mas-Bermejo P. Cuba: Time to Expand Health in All Policies. MEDICC Rev 2016 Oct;18(4):48.

(33) Reardon S. Mosquito guns and heavy fines: how Cuba kept Zika at bay for so long. Nature 2016 Aug 18;536(7616):257-8.

(34) Singh RK, Dhama K, Karthik K, Tiwari R, Khandia R, Munjal A, et al. Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An Update. Front Microbiol 2018 Jan;8:2677. doi: 10.3389/fmicb.2017.02677. eCollection@2017.:2677.

(35) Azeredo EL, Dos Santos FB, Barbosa LS, Souza TMA, Badolato-Correa J, Sanchez-Arcila JC, et al. Clinical and Laboratory Profile of Zika and Dengue Infected Patients: Lessons Learned From the Co-circulation of Dengue, Zika and Chikungunya in Brazil. PLoS Curr 2018 Feb 15;10. doi: 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5.:10.

(36) Fernandez-Salas I, Diaz-Gonzalez EE, Lopez-Gatell H, Alpuche-Aranda C. Chikugunya and zika virus dissemination in the Americas: different arboviruses reflecting the same spreading routes and poor vector-control policies. Curr Opin Infect Dis 2016 Oct;29(5):467-75.

(37) Goddard J. Essential Facts About Mosquito Control and Zika Virus. Am J Med 2016 Nov;129(11):1149-52.

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2019 Panorama. Cuba y Salud

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.